Maze Therapeutics, Inc. - Common Stock
Maze Therapeutics, Inc. - Common Stock
Share · US5787841007 · MAZE (XNAS)
Overview Financial Indicators
12,90 USD
-2,71 % -0,36 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 21:05

Current Prices from Maze Therapeutics, Inc. - Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
MAZE
USD
06.06.2025 21:05
12,90 USD
13,26 USD
-2,71 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 29,39 % 42,54 % 9,97 % 7,50 % 7,50 % 7,50 %

Company Profile for Maze Therapeutics, Inc. - Common Stock Share

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs includes MZE829, an oral small molecule inhibitor of apolipoprotein L1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor of the solute transporter SLC6A19, which is in phase I clinical trial for the treatment of chronic kidney disease. Maze Therapeutics, Inc. was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.

Company Data

Name Maze Therapeutics, Inc. - Common Stock
Company Maze Therapeutics, Inc.
Symbol MAZE
Website https://www.mazetx.com
Primary Exchange XNAS NASDAQ
ISIN US5787841007
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D.
Market Capitalization 366 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 171 Oyster Point Blvd, 94080 South San Francisco
IPO Date 2025-01-31

Ticker Symbols

Name Symbol
NASDAQ MAZE

More Shares

Investors who Maze Therapeutics, Inc. - Common Stock hold also have the following shares in their portfolio:
INTEL CORP 16/26
INTEL CORP 16/26 Bond
PET. MEX. 15/27 MTN
PET. MEX. 15/27 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025